Skip to main content

For medical researchers who aim to understand the patient experience, “collecting abundant social-media data is cost-effective, does not involve burdening participants, and is available in real time,” Graciela Gonzalez Hernandez, PhD, commented” and it may help highlight the voices of groups typically underrepresented in clinical trials.

Read the article in The Wall Street Journal